NPPB and Stroke: For secondary outcomes, participants with NT-proBNP >15 pmol/L were at significantly increased risks of both stroke/SE/cardiovascular death and all-cause death compared with those having lower levels (HR 1.60 [95% CI, 1.32–1.95] and 1.91 [95% CI, 1.61–2.26], respectively).